There are two case reports of women treated with off-label PTH(1-34) during pregnancy, one with postoperative hypoparathyroidism and the second with autosomal dominant hypocalcemia type 1, with no apparent adverse effect to the mother or child (14, 15). This evidence concerns the gene PTH and autosomal dominant hypocalcemia 1.